Exelon Transdermal and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Exelon Transdermal and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rivastigmine
Brand name: Exelon
Synonyms: Exelon
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Exelon Transdermal-Insulin degludec
- Exelon Transdermal-Insulin Degludec (U-100) Prefilled Pens
- Exelon Transdermal-Insulin Degludec (U-100) Vials
- Exelon Transdermal-Insulin Degludec (U-200) Prefilled Pens
- Exelon Transdermal-Insulin degludec and liraglutide
- Exelon Transdermal-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Exemestane
- Insulin aspart, recombinant Subcutaneous-Exemestane Tablets
- Insulin aspart, recombinant Subcutaneous-Exenatide
- Insulin aspart, recombinant Subcutaneous-Exenatide extended release
- Insulin aspart, recombinant Subcutaneous-Exenatide Extended-Release Injection (Bydureon BCise)
- Insulin aspart, recombinant Subcutaneous-Exenatide Extended-Release Injection (Bydureon) (Pens)